Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Pfiser's List of Grants and Charitable Contributions
- Details
- Category: Pfizer
![Pfizer Pfizer](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Lapatinib (Tykerb/Tyverb) to be investigated in landmark early breast cancer trial
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
Boehringer Ingelheim announces commitment to progressing science with the Bouquet Studies
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
International study to evaluate efficacy and safety in treating a leading cause of blindness
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Highlight Potential of Novel Oral Compound for Gaucher Disease
- Details
- Category: Genzyme
![Genzyme Corp. Genzyme Corp.](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
More Pharma News ...
- Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe
- European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus®)
- Novo Nordisk researchers nominated for Europe's top innovation prize
- GlaxoSmithKline commences tender offer to acquire Sirtris Pharmaceuticals
- Abbott, Takeda Conclude TAP Joint Venture
- Esperion Therapeutics Completes $22.75 M Series A Financing
- Lundbeck expands geographical rights for Circadin®